Home › Funds › GABELLI & Co INVESTMENT ADVISERS, INC. › TECH

GABELLI & Co INVESTMENT ADVISERS, INC. position in TECH

BIO-TECHNE CORP · Health Care

GABELLI & Co INVESTMENT ADVISERS, INC. reported holding 250,710 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$18.2M, representing 2.87% of its reported portfolio and ranking #5 among its reported holdings. GABELLI & Co INVESTMENT ADVISERS, INC. has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)250.71K sh
Reported value held$18.17M
Portfolio Weight2.87%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How GABELLI & Co INVESTMENT ADVISERS, INC.'s TECH position evolved

GABELLI & Co INVESTMENT ADVISERS, INC. first disclosed a stake in TECH in Q2 2026 at 161,250 shares (US$11.4M). The position peaked in Q3 2026 at 250,710 shares, worth US$18.2M. Across 2 filings, GABELLI & Co INVESTMENT ADVISERS, INC. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 250,710 shares valued at US$18.2M — an increase of 89,460 shares quarter over quarter.. Notable position changes include a 55% increase in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 161.25K $11.39M New
Q3 2026 250.71K $18.17M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 27 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has GABELLI & Co INVESTMENT ADVISERS, INC. held TECH?

GABELLI & Co INVESTMENT ADVISERS, INC. has disclosed TECH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is GABELLI & Co INVESTMENT ADVISERS, INC.'s current position in TECH?

As of Q3 2026, GABELLI & Co INVESTMENT ADVISERS, INC. holds 250.71K shares of TECH (BIO-TECHNE CORP), valued at $18.17M, representing 2.87% of its reported portfolio and ranking #5.

Has GABELLI & Co INVESTMENT ADVISERS, INC. been buying or selling TECH?

In the latest 13F filing (Q3 2026), GABELLI & Co INVESTMENT ADVISERS, INC. increased its position in TECH. The position peaked in Q3 2026 at 250.71K shares.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.